Skip to content

Castle Biosciences CSTL Business Segments — Personnel costs

Similar metrics at other companies

XPEL, Inc. logo
XPELReportable Segment — Personnel costs
$16.98M+19.2%
Concentra Group Holdings Parent logo
CONReportable Segment — Personnel expenses
$322.17M+14.4%
CareDx logo
CDNAReportable Segment — Personnel cost
$42.19M+37.2%
Prime Medicine logo
PRMEReportable Segment — Personnel expenses
$5.53M-22.7%
F&G Annuities & Life logo
FGReportable Segment — Personnel costs
$60M-10.4%
Arlo Technologies logo
ARLOReportable Segment — Personnel-related expense
$19.87M+13.1%

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$694.86M+29.9%
Enterprise value$667.82M+41.8%
P/S+0.5×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept cstl:PersonnelCosts.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's business segments — personnel costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Castle Biosciences's business segments — personnel costs?
Castle Biosciences (CSTL) reported business segments — personnel costs of $58.37M in Q1 2026.
How has Castle Biosciences's business segments — personnel costs changed year-over-year?
Castle Biosciences's business segments — personnel costs increased by 11.8% year-over-year, from $52.2M to $58.37M.
What is the long-term trend for Castle Biosciences's business segments — personnel costs?
Over 3 years (2022 to 2025), Castle Biosciences's business segments — personnel costs has grown at a 16.0% compound annual growth rate (CAGR), from $134.56M to $209.82M.
What does business segments — personnel costs mean?
Includes all compensation-related expenses for employees within the reportable segment, such as salaries, bonuses, and benefits. Monitoring this helps evaluate the scalability of the workforce relative to revenue growth and operational output.